The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.<\/p>\n
2153 ET \u2013 Bumrungrad Hospital\u2019s earnings growth is likely to be slow, Thanachart Securities\u2019 Siriporn Arunothai says in a research report. The brokerage sees higher uncertainty over the Thai hospital\u2019s Middle East patient flows owing to cost-control policies by the region\u2019s governments and intensifying competition from peers. Its new hospital in Phuket, along with three new buildings planned in Bangkok in 2027, will probably contribute losses in the early years of operation. Bumrungrad Hospital is expected to post slow growth in the years ahead, with the brokerage projecting 3.4% EPS CAGR over 2026-2028. It downgrades the stock to hold from buy and lowers the target price to THB187.00 from THB216.00. Shares last closed at THB176.00. (ronnie.harui@wsj.com<\/a>)<\/p>\n Copyright \u00a92025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8<\/p>\n","protected":false},"excerpt":{"rendered":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET,…\n","protected":false},"author":2,"featured_media":187882,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[275],"tags":[2786,10852,105218,50843,97416,82654,18,82653,3334,135,475,474,82485,82483,82484,19,17,3544,105325,82482,2900,9436,44285,4434,26243,391,41580],"class_list":{"0":"post-187881","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-asia","9":"tag-asia-pacific","10":"tag-biological-therapy","11":"tag-biopharmaceuticals","12":"tag-biotechnology-services","13":"tag-developing-economies","14":"tag-eire","15":"tag-emerging-market-countries","16":"tag-general-news","17":"tag-health","18":"tag-health-care","19":"tag-healthcare","20":"tag-healthcare-provision","21":"tag-healthcare-life-sciences","22":"tag-hospital-care","23":"tag-ie","24":"tag-ireland","25":"tag-life-sciences","26":"tag-linkendrnrealtime-linkedarticle-dnco20251118006699","27":"tag-newsplus","28":"tag-pharmaceuticals","29":"tag-political","30":"tag-political-general-news","31":"tag-southeast-asia","32":"tag-synd","33":"tag-thailand","34":"tag-wsj-pro-wsj-com"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/115573024550486839","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/187881","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=187881"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/187881\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/187882"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=187881"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=187881"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=187881"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}